A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV

详细信息    查看全文

• 作者：Ran Yan¹ ; ^a ; Zhenhuan Zhao¹ ; ^a ; Yawen He^a ; Lin Wu^a ; Dawei Cai^a ; Wei Hong^a ; Yingliang Wu^a ; Zhijian Cao ; ^a ; ^{zjcao@whu.edu.cn} ; Congyi Zheng ; ^a ; ^{cctcc202@whu.edu.cn} ; Wenxin Li ; ^a ; ^{liwxlab@whu.edu.cn}
• 关键词：Scorpion venom ; HCV ; Antiviral peptide ; Virocidal mechanism
• 刊名：Peptides
• 出版年：2011
• 出版时间：January 2011
• 年：2011
• 卷：32
• 期：1
• 页码：11-19
• 全文大小：715 K

文摘

Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma. There is no vaccine available for HCV, and almost half of patients cannot be cured using standard combination therapy. Thus, new anti-HCV strategies and drugs are urgently needed. Here, the gene encoding a new α-helical peptide, Hp1090, was screened from the venomous gland cDNA library of the scorpion Heterometrus petersii. Structural analysis showed that Hp1090 is an amphipathic α-helical peptide. In vitro HCV RNA inhibitory assays indicated that Hp1090 peptide inhibited HCV infection with an IC₅₀ of 7.62 μg/ml (5.0 μM), whereas Hp1035 peptide, showing high homology to Hp1090, exhibited no anti-HCV activity. Hp1090 acted as a viricide against HCV particles in vitro and prevented the initiation of HCV infection. Furthermore, this peptide interacted with HCV particles directly and rapidly permeabilized phospholipid membranes. Collectively, it seems that Hp1090 is virocidal for HCV in vitro, directly interacting with the viral membrane and decreasing the virus infectivity. These results suggest that Hp1090 could be considered an anti-HCV lead compound with virocidal mechanism that offers a potential therapeutic approach to HCV infection. Our work opens a new avenue for antiviral drug discovery in natural scorpion venom.